Published in Infect Immun on August 21, 2006
Role of pore-forming toxins in bacterial infectious diseases. Microbiol Mol Biol Rev (2013) 1.91
Complete genome sequence and comparative metabolic profiling of the prototypical enteroaggregative Escherichia coli strain 042. PLoS One (2010) 1.90
Alternate SlyA and H-NS nucleoprotein complexes control hlyE expression in Escherichia coli K-12. Mol Microbiol (2007) 1.13
Characterization of anti-Salmonella enterica serotype Typhi antibody responses in bacteremic Bangladeshi patients by an immunoaffinity proteomics-based technology. Clin Vaccine Immunol (2010) 1.00
Neurologic manifestations associated with an outbreak of typhoid fever, Malawi--Mozambique, 2009: an epidemiologic investigation. PLoS One (2012) 0.98
Comparative proteomic analysis of the PhoP regulon in Salmonella enterica serovar Typhi versus Typhimurium. PLoS One (2009) 0.98
Cytotoxicity of the Bacillus cereus Nhe enterotoxin requires specific binding order of its three exoprotein components. Infect Immun (2010) 0.97
Immunoproteomic analysis of antibody in lymphocyte supernatant in patients with typhoid fever in Bangladesh. Clin Vaccine Immunol (2013) 0.86
Mutations affecting export and activity of cytolysin A from Escherichia coli. J Bacteriol (2010) 0.81
Soluble Oligomers of the Pore-forming Toxin Cytolysin A from Escherichia coli Are Off-pathway Products of Pore Assembly. J Biol Chem (2016) 0.77
RpoS integrates CRP, Fis, and PhoP signaling pathways to control Salmonella Typhi hlyE expression. BMC Microbiol (2014) 0.75
Typhoid fever. N Engl J Med (2002) 12.96
Vesicle-mediated export and assembly of pore-forming oligomers of the enterobacterial ClyA cytotoxin. Cell (2003) 3.88
A cytolysin encoded by Salmonella is required for survival within macrophages. Proc Natl Acad Sci U S A (1994) 2.87
Typhoid and paratyphoid fever in travellers. Lancet Infect Dis (2005) 2.57
SlyA, a transcriptional regulator of Salmonella typhimurium, is required for resistance to oxidative stress and is expressed in the intracellular environment of macrophages. Infect Immun (1997) 1.94
Paratyphoid fever in India: An emerging problem. Emerg Infect Dis (1999) 1.89
E. coli hemolysin E (HlyE, ClyA, SheA): X-ray crystal structure of the toxin and observation of membrane pores by electron microscopy. Cell (2000) 1.86
Co-regulation of Salmonella enterica genes required for virulence and resistance to antimicrobial peptides by SlyA and PhoP/PhoQ. Mol Microbiol (2005) 1.80
Induction of haemolytic activity in Escherichia coli by the slyA gene product. Mol Microbiol (1996) 1.61
Analysis of the SlyA-controlled expression, subcellular localization and pore-forming activity of a 34 kDa haemolysin (ClyA) from Escherichia coli K-12. Mol Microbiol (1999) 1.55
SlyA, a regulatory protein from Salmonella typhimurium, induces a haemolytic and pore-forming protein in Escherichia coli. Mol Gen Genet (1995) 1.45
The Escherichia coli K-12 sheA gene encodes a 34-kDa secreted haemolysin. Mol Microbiol (1997) 1.45
Cytocidal and apoptotic effects of the ClyA protein from Escherichia coli on primary and cultured monocytes and macrophages. Infect Immun (2000) 1.39
Molecular analysis of the cytolytic protein ClyA (SheA) from Escherichia coli. Mol Microbiol (1999) 1.37
Differential regulation of multiple proteins of Escherichia coli and Salmonella enterica serovar Typhimurium by the transcriptional regulator SlyA. J Bacteriol (2002) 1.37
Transcriptional control of the antimicrobial peptide resistance ugtL gene by the Salmonella PhoP and SlyA regulatory proteins. J Biol Chem (2004) 1.37
Characterization of a pore-forming cytotoxin expressed by Salmonella enterica serovars typhi and paratyphi A. Infect Immun (2002) 1.36
Silencing and activation of ClyA cytotoxin expression in Escherichia coli. J Bacteriol (2000) 1.36
Interaction of the Salmonella typhimurium transcription and virulence factor SlyA with target DNA and identification of members of the SlyA regulon. J Biol Chem (2002) 1.32
Seroprevalence of Babesia infections in humans exposed to ticks in midwestern Germany. J Clin Microbiol (2002) 1.29
SlyA regulates function of Salmonella pathogenicity island 2 (SPI-2) and expression of SPI-2-associated genes. Infect Immun (2005) 1.20
Molecular analysis of cytolysin A (ClyA) in pathogenic Escherichia coli strains. J Bacteriol (2004) 1.17
The molecular basis for the differential regulation of the hlyE-encoded haemolysin of Escherichia coli by FNR and HlyX lies in the improved activating region 1 contact of HlyX. Microbiology (1997) 1.16
Structure-function relationships of a novel bacterial toxin, hemolysin E. The role of alpha G. J Biol Chem (2000) 1.13
Regulation of Escherichia coli hemolysin E expression by H-NS and Salmonella SlyA. J Bacteriol (2004) 1.10
PhoP-responsive expression of the Salmonella enterica serovar typhimurium slyA gene. J Bacteriol (2003) 1.10
The bacteriophage-associated ehly1 and ehly2 determinants from Escherichia coli O26:H- strains do not encode enterohemolysins per se but cause release of the ClyA cytolysin. Int J Med Microbiol (2002) 0.91
A multiplex real-time PCR assay for rapid detection and differentiation of 25 bacterial and fungal pathogens from whole blood samples. Med Microbiol Immunol (2007) 2.64
Molecular characterization of blaNDM-1 in an Acinetobacter baumannii strain isolated in Germany in 2007. J Antimicrob Chemother (2011) 2.26
Biological cost of rifampin resistance from the perspective of Staphylococcus aureus. Antimicrob Agents Chemother (2002) 1.79
Molecular analysis of fusidic acid resistance in Staphylococcus aureus. Mol Microbiol (2003) 1.76
Linezolid resistance in Staphylococcus aureus: gene dosage effect, stability, fitness costs, and cross-resistances. Antimicrob Agents Chemother (2008) 1.51
Improved detection of blood stream pathogens by real-time PCR in severe sepsis. Intensive Care Med (2009) 1.51
Zoonotic babesiosis: overview of the disease and novel aspects of pathogen identity. Ticks Tick Borne Dis (2009) 1.42
Differential regulation of multiple proteins of Escherichia coli and Salmonella enterica serovar Typhimurium by the transcriptional regulator SlyA. J Bacteriol (2002) 1.37
Potential clinical utility of polymerase chain reaction in microbiological testing for sepsis. Crit Care Med (2009) 1.29
Molecular analysis of the thymidine-auxotrophic small colony variant phenotype of Staphylococcus aureus. Int J Med Microbiol (2007) 1.29
First case of human babesiosis in Germany - Clinical presentation and molecular characterisation of the pathogen. Int J Med Microbiol (2007) 1.28
Is serological testing a reliable tool in laboratory diagnosis of syphilis? Meta-analysis of eight external quality control surveys performed by the german infection serology proficiency testing program. J Clin Microbiol (2006) 1.17
Individual cases of autochthonous malaria in Evros Province, northern Greece: serological aspects. Parasitol Res (2002) 1.06
ClyA cytolysin from Salmonella: distribution within the genus, regulation of expression by SlyA, and pore-forming characteristics. Int J Med Microbiol (2008) 1.05
Compensatory adaptation to the loss of biological fitness associated with acquisition of fusidic acid resistance in Staphylococcus aureus. Antimicrob Agents Chemother (2005) 1.04
Characterization of anti-Salmonella enterica serotype Typhi antibody responses in bacteremic Bangladeshi patients by an immunoaffinity proteomics-based technology. Clin Vaccine Immunol (2010) 1.00
Surface-associated motility, a common trait of clinical isolates of Acinetobacter baumannii, depends on 1,3-diaminopropane. Int J Med Microbiol (2012) 0.98
The borrelial fibronectin-binding protein RevA is an early antigen of human Lyme disease. Clin Vaccine Immunol (2009) 0.91
Early production of IL-22 but not IL-17 by peripheral blood mononuclear cells exposed to live Borrelia burgdorferi: the role of monocytes and interleukin-1. PLoS Pathog (2010) 0.90
Thymidine-dependent Staphylococcus aureus small-colony variants: human pathogens that are relevant not only in cases of cystic fibrosis lung disease. J Clin Microbiol (2008) 0.88
Borrelia burgdorferi complement regulator-acquiring surface protein 2 (CspZ) as a serological marker of human Lyme disease. Clin Vaccine Immunol (2007) 0.88
[Flap Amputation in Mycobacterium chelonae Keratitis after Laser-in-situ Keratomileusis (LASIK)]. Klin Monbl Augenheilkd (2003) 0.86
Immunoproteomic analysis of antibody in lymphocyte supernatant in patients with typhoid fever in Bangladesh. Clin Vaccine Immunol (2013) 0.86
Comparison of in vitro activities of tigecycline, doxycycline, and tetracycline against the spirochete Borrelia burgdorferi. Ticks Tick Borne Dis (2010) 0.85
Systematic analysis highlights the key role of TLR2/NF-kappaB/MAP kinase signaling for IL-8 induction by macrophage-like THP-1 cells under influence of Borrelia burgdorferi lysates. Int J Biochem Cell Biol (2008) 0.83
Primary intestinal aspergillosis after high-dose chemotherapy and autologous stem cell rescue. Pediatr Infect Dis J (2006) 0.82
Generation and characterization of anti-Candida T cells as potential immunotherapy in patients with Candida infection after allogeneic hematopoietic stem-cell transplant. J Infect Dis (2007) 0.78
Occurrence and characteristics of the cytolysin A gene in Shigella strains and other members of the family Enterobacteriaceae. FEMS Microbiol Lett (2008) 0.78
In vitro susceptibility of Borrelia spielmanii to antimicrobial agents commonly used for treatment of Lyme disease. Antimicrob Agents Chemother (2008) 0.75
In vitro activities of faropenem, ertapenem, imipenem and meropenem against Borrelia burgdorferi s.l. Int J Antimicrob Agents (2007) 0.75
[Babesiosis in an immunocompromised German patient]. Med Klin (Munich) (2008) 0.75
Real-time PCR-based identification of bacterial and fungal pathogens from blood samples. Methods Mol Biol (2015) 0.75